Viewing Study NCT01426802


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:43 AM
Study NCT ID: NCT01426802
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2011-07-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module